This infographic explains how 2’-fucosyllactose (2’-FL)—the most abundant HMO in 75-85% of mothers’ breast milk—interacts in the gut, immune system and brain. It also presents the important outcomes and benefits of 2’-FL, as discovered through preclinical and clinical research.
AUTHOR(S): The ANHI team
DATE: 10 December 2018
UK-N/A-2300062 | February 2023
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
UK-N/A-2200443 | June 2022
Stay Connected